The best angels and angel organizations have a lot of investment opportunities, whether discovered on their own or directed to them. They have the high-class problem of getting those opportunities down to a manageable number for true consideration. It’s a two or three-part process, screening deals into a smaller group of “semi-finalists” who can go through a deeper vetting process that lead to “finalists,” who then present to the investors and are selected for due diligence.
As part of this week’s Business Angel Week, HBAN (Halo Business Angel Network), the all-island group responsible for the promotion of business angel investment in Ireland, today announces plans to increase the amount invested in Irish start-ups by HBAN angels to €25 million per year by 2020. This will see HBAN increasing angel investment by 17% per year for the next four years.
The toughest moment in a new angel’s investing career: a very large round has lots of momentum – it has been expanded and is still over-subscribed. And it is a classic case as these things go, driven by the usual factors: little bit later stage with some traction, so risk is perceived as lower, great pitch by an appealing CEO, backed by a seemingly good team, momentum in the round building quickly, a product people can understand that is already built and in the stream of commerce, and, perhaps most importantly, a perception of scarcity as the round filled up.
Dublin, 31st October 2017 – HBAN (Halo Business Angel Network), the all-island group responsible for the promotion of business angel investment in Ireland and a joint initiative of Enterprise Ireland and InterTradeIreland, today announces the appointment of Rowan Devereux to the Chair of the Bloom Equity Syndicate. Rowan succeeds Anthony Bermingham as Chair and in his new role, he aims to recruit new angels, build the profile of the syndicate and work with HBAN in selecting high potential start-ups to present at monthly syndicate meetings.
Dublin, 19th October, 2017 – HBAN (Halo Business Angel Network), the all-island organisation responsible for the promotion of business angel investment and a joint initiative of Enterprise Ireland and InterTradeIreland, today announces a €1.8 million investment in Cork-based medtech company, AventaMed. The investment – which includes €1.6 million angel funding, the largest single HBAN angel investment to date – will fund AventaMed through FDA (Food and Drug Administration) clearance and commercialisation of the Solo Tympanostomy Tube Device (Solo TTD) which enables the quick and simple insertion of ear grommets.
HBAN National Director John Phelan was interviewed by the Independent where he spoke about the importance of exit strategies for investors as well as discussing previous investments made by HBAN business angels.
If you‘re a high potential Start Up that has a new innovative product or service ready for commercialisation and/or have achieved some early traction and are raising finance to scale internationally please contact us.